ProfileGDS4718 / 224736_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 94% 92% 93% 95% 96% 96% 93% 91% 92% 94% 93% 94% 96% 95% 93% 92% 95% 94% 97% 95% 94% 92% 91% 95% 95% 91% 97% 92% 96% 94% 97% 91% 90% 92% 95% 95% 94% 92% 93% 91% 95% 95% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.9460993
GSM549102patient 115, normal, homogenized [OPG study]9.9034794
GSM549104patient 119, normal, homogenized [OPG study]9.6886692
GSM549108patient 138, normal, homogenized [OPG study]9.7466693
GSM549119patient 077, normal, homogenized [OPG study]10.310995
GSM549133patient 032, cancer, homogenized [OPG study]10.704696
GSM549139patient 042, cancer, homogenized [OPG study]10.330196
GSM549099patient 107, normal, homogenized [OPG study]9.6907993
GSM549109patient 139, normal, homogenized [OPG study]9.3069591
GSM549110patient 046, normal, homogenized [OPG study]9.6064692
GSM549114patient 063, normal, homogenized [OPG study]10.080294
GSM549122patient 082, normal, homogenized [OPG study]9.7972993
GSM549134patient 033, cancer, homogenized [OPG study]10.080894
GSM549136patient 036, cancer, homogenized [OPG study]10.638696
GSM549140patient 044, cancer, homogenized [OPG study]10.290495
GSM549111patient 047, normal, homogenized [OPG study]9.9062193
GSM549113patient 057, normal, homogenized [OPG study]9.6978492
GSM549132patient 031, cancer, homogenized [OPG study]10.175595
GSM549137patient 038, cancer, homogenized [OPG study]9.9638194
GSM549142patient 047, cancer, homogenized [OPG study]10.598997
GSM549100patient 110, normal, homogenized [OPG study]10.296295
GSM549107patient 135, normal, homogenized [OPG study]9.9775994
GSM549115patient 068, normal, homogenized [OPG study]9.7798692
GSM549116patient 072, normal, homogenized [OPG study]9.4612891
GSM549120patient 078, normal, homogenized [OPG study]10.37495
GSM549131patient 030, cancer, homogenized [OPG study]10.220395
GSM549118patient 074, normal, homogenized [OPG study]9.4297691
GSM549129patient 027, cancer, homogenized [OPG study]10.466597
GSM549123patient 088, normal, homogenized [OPG study]9.5573592
GSM549124patient 006, cancer, homogenized [OPG study]10.457596
GSM549126patient 015, cancer, homogenized [OPG study]9.8597694
GSM549128patient 025, cancer, homogenized [OPG study]10.681797
GSM549103patient 117, normal, homogenized [OPG study]9.3603791
GSM549117patient 073, normal, homogenized [OPG study]9.3337490
GSM549138patient 041, cancer, homogenized [OPG study]9.61992
GSM549141patient 045, cancer, homogenized [OPG study]10.187895
GSM549130patient 028, cancer, homogenized [OPG study]10.162395
GSM549101patient 111, normal, homogenized [OPG study]9.8550894
GSM549105patient 128, normal, homogenized [OPG study]9.4903892
GSM549106patient 134, normal, homogenized [OPG study]9.8107193
GSM549112patient 048, normal, homogenized [OPG study]9.3663991
GSM549125patient 011, cancer, homogenized [OPG study]10.02295
GSM549127patient 024, cancer, homogenized [OPG study]9.9971195
GSM549135patient 035, cancer, homogenized [OPG study]10.778497